Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

Th.C.2 I I,Th.C.432,Th.C.4360, Th.C.4498, Th.C.4648, Th.C.4684, Th.C.48 I8, Th.C.484 I, Th.D.46 1, Th. D.5037, Th. D.5042, Th. D.5045, Th. D.5047, Th. D.5049, Th. D.5052, Tu.C.2477, Tu.C.26 I17, Tu.C.2635, Tu.C.2660,Tu.C.266 I,Tu.C.2666, Tu. C. 2669, Tu. C.2670, Tu. C.2672, Tu.C.2673, Tu.D2766, Tu. D.2786, Tu.D2802,Tu.D2967, We.C.35 I 1, We.C.352 I, We.D.485 condoms, use by students Mo.D.1692, MoD. 1730, Mo.D.582, Pub.C.I1184, Pub.C.l1194, Pub.C.l1196, Pu b. C.1209, Pu b. C.1215, Pu b. C.1218, Pub.D. 1324, Pub.D. 1359, Pub.D, 1368, Pub.D. I1369. Pub.D. 1371, Pub.D. 1432, Pub.D. I 450, Th.C.4425, Th.C.4446, Th.C.4466, Th.C.4472,Th.C.4473, Th.C.4492, Th.C.4493, Th.C.4639, Th. D.445, Th. D.49 I19, Th. D.4922, Tu.C.2667,Tu.C.335,Tu.D.279 1, Tu. D.2800, Tu. D.2801I, Tu. D.2802, Tu.D.28 I 8,Tu.D.474, We.C.3508 condoms, use by women MoD. 1714, Mo.D. 1852, Mo.D.246, Pub.C.1217, Pub.C. 1219, Th.B.41 19, Th.C.430,Th.C.43 I,Th.C.4467, Th.C.4474, Th.C.4478, Th.C.4483, Th.C.4500, Th.C.4506, Th.C.45 10, Th.C.4652, Th.C.4667,Th.C.4777, Th.D.241I,Th.D.255,Th.D.454,Th.D.4960, Th. D.5 I196, Tu.C.245 I, Tu.C.2470, Tu.C.2475, Tu.C.2665,Tu.C.453,Tu.D. 132, Tu. D. 13 3, Tu. D.2727, Tu. D.2745, Tu.D.2769,Tu.D.2778,Tu.D.2837, We.C.205, We.D.3746 confidentiality Mo.B. I1167, Mo.B.550, MoD. 1915, Pub.C. 11I77, Pub.C. I1222, Th.C.4596, Th.C.4600,Th.C.4632,Th.C.4655, Th.C.47 I I,Th.D.4954,Th.D.4960, Th. D.50 I13, Th. D.5040, Th. D.508 I, Th. D.5 I1I3, Tu. D.2852, Tu. D.2908, Tu.D.2929, We.B,33 32, We.D.3608, We.D.36 I18, We.D.3729, We.D.3750, We.D.3770, We.D.39 IS consent Mo.C.2 I I, Pub.C.l 177,Th.C.4390, Th.D.494 I, Th. D.4960, Th. D.4995, Th.D.5 I I3,Tu.B.520, We.B.3 147, We.C.3586 contact tracing, SEE partner notification Mo.C. I1585, Mo.C. I1642, Pub.D. I1383, Th.B.4 I12 I,Th.C.4625,Th.C.4627, Th C.4628, We.D.3655 contraception Mo.B. I1198, Mo.C.572, Pub.C. 1261, Th.B.4 I 37,Th.C.433, Th.C.434, Th. C.4429, Th. C.4467, Th. C.4472, Th.C.4477, Th.C.4495,Th.C.450 I, Th.C.45 I 0,Th.C.4855,Th.D.240, Th.D.49 32, Th.D.5 I196, Tu.C.2695, Tu.C.563,Tu.D.2728, We.C.3508 control groups Tu.B.2304, We.D.3807 coping We.D.3873, We.D.600, We.D.6 13 core proteins ThB.4280,Tu.B.2 164 corticosteroids Mo.B.1263, Mo.B. I 297, Th.B. 195, Th.B.433 I,Tu.B.2272,Tu.B.2378,Tu.B.4 14, We.B.3320, We.B.3366, We.D.242 cost, direct Mo,.I 172, Mo.D.1846, Pub.C.121 I, Th.C.4809,Th.C.482 I,Th.D.496 1, Th.D.4966, Th.D.4969, Th.D.4972, Th.D.4984,Tu.B.4 I 4,Tu.C.20 I,Tu.D.250, Tu.D.25 I,Tu.D.255 cost, health care MoC.120, Ma.C. 1624, MoC. 1655, Pub.B. I 037, Th.B.400, Th.C.48 19, Th.D.4969,Th.D.5003,Th.D.5004, Th. D.50 I14, Th. D.50 I18, Th. D.5066, Th. D. 5072, Tu. B.2 I160, Tu. D.250, Tu. D.254, Tu.D.255, We.B. 171, We.B. 174, We.B.3 148, We.B.3 ISO, We.B.3 154, We.D.235, We.D.364, We.D.3689, We.D.3842 cost, hospital care Mo.B. I I73,Th.B.4 I 23,Th.C.4804, Th.C.4807, Th.C.4809, Th.C.48 14, Th.C.48 I 6,Th.C.4825,Th.D.4968, Th.D.5023,Tu.B.2 I 38,Tu.B.2 I139, Tu. B.2 I149, Tu. B.2 I157, Tu. D.25 0, Tu. D.25 2, Tu.D.254,Tu.D.255, We.C.3449 cost, indirect MoC. ISIIS, MoC. I557,Th.D.4966, Th. D.4975, Th. D.4976, Th. D.4984, Tu.D. I 36,Tu.D.250 cost, projection Mo.C. 1489, Mo.D. I 846,Th.C.20 1, Th.C.482 I,Th.D.4966,Th.D.4975, Tu.D.25 I,Tu.D253, We.D.360, We.D.362, We.D.3842 cost, societal Mo.C. 1570, MoC. I 624,Th.D.4969, Th.D.4972,Th.D.4975,Th.D.502 I, Th.D.5072,Th.D.5074, We.B.3264, We.C.583, We.D.360 cost, treatment Mo.B. I1170, Mo.B.1I 174, MoC. 1626, MoD. 19 31,Th. B.4 I107, Th. B.4 116, Th.C.4639,Th.C.4820,Th.C.4834, Th. D.4973, Th. D.5023, Tu.B8.2 159, Tu.B.2273,Tu.B.4 I 5,Tu.C.2448,Tu.C.324, Tu.D.250, We.B.3 I126, We.B.3 ISO, We.B.3 I158, We.B.3296, We.D.3667, We.D.3700, We.D.3720 cost-effectiveness MoB. I 154, Mo.B. I 169, Mo.B. I1171, Mo.B. 1172, Mo.B. I1182, Mo. B.5 33, Ma.C. 1581, MoC. 1626, Mo.C.342, Mo.C.444, Mo.D. 1833, Mo.D. 1847, Mo.D.24 I, Pub.B. 1095, Pub.C. I1I76, Pub.D. I 446,Th.B.295,Th.B.303,Th.C.20 I, Th. C.4 I13, Th. C.4544, Th. C.4592, Th.C.4606,Th.C.46 I S,Th.C.4624, Th.C.4626,Th.C.4740,Th.C.48 16, Th.C.48 I17, Th.C.4822, Th.C.4823, Th.D.37 I,Th.D.5004,Th.D.502 1, Tu. B. 2 15 7,Tu. B. 2 5 8,Tu. B. 2 I61, TuB.2 19 I, Tu. B.2273, Tu. B.4 I14, Tu. B.4 IS, Tu.D.2924, We.B.3 141,We.B.3 154, Pub.C. I1I28, Pub.C. I1I60, Pub.C. I1I77, Pub.C. I1I90, Pub.C. I1206, Pub.C. I2 I6. Pub.C. 122 1, Pub.C. I1227, Pub.C. I1242, Pub.C. 1245, Pub.C. I1246, Pub.C. 1269, Pub.D. 1303, Pub.D. I1332, Pub.D. 1358, Pub.D.1376, Pub.D.1383, Pub.D.1418, Pu b.D. 1420, Pu b.D. 1425, Pu b.D. 1427, Pub.D. 1428, Pub.D. 1456, Pub.D. 148 I, Pub.D. I 492, Th. B.4 I105, Th. B.4 120, Th.C.43 70,Th.C.4375,Th.C.4380, Th.C.4390,Th.C.4570,Th.C.4609, Th.C.4620,Th.C.4627,Th.C.4629, Th.C.4655, Th.C.4663, Th.C.47 12, Th.C.4724, Th.C.4729, Th.C.4802, Th.C.4829,Th.C.4855,Th.D.4893, Th.D.49 I 5,Th.D.5036,Th.D.5040, Th. D.5090, Th. D.5 I103, Th. D.51I0O, Th. D.5 I1I3, Th. D.5 I126, Th. D.5 170, Th.D.5204,Tu.B.2249,Tu.C.2 I13, Tu.C.2590,Tu.C.45 I,Tu.C.455,Tu.D. 135, Tu. D.2729, Tu. D.2752, Tu. D.2799, Tu.D.280 I, Tu. D.28 I10, Tu. D.28 19, Tu.D.2869,Tu.D.2903,Tu.D.2938, Tu.D,36 I,Tu.D.460, We.B.3 147, We.B.331 I,We.C.351 I,We.C.3543, We.C.3586, We.D.36 I10, We.D.3622, We.D.3692, We.D.3693, We.D.3699, We.D.3705, We.D.3709, We.D.37 13, We.D.3725, We.D.3729, We.D.3736, We.D.3738, We.D.3750, We.D.3766, We.D.3838, We.D.386 I, We.D.3864, We.D.3865, We.D.3866, We.D.3874, We.D.613 crack, SEE also cocaine Mo.C.222, MoD. 1910, Pub.C. 1133, Pub.C. 1255, Pub.D. 147 1,Th.C.4674, Th. D.5 I106, Tu. C.2475, Tu. C.2478, Tu.C.2484, Tu.C.2492, Tu.C.2496, Tu.C.2672,Tu.C.56 I, We.C.226, We.C.3423, We.C.3565 criminal justice system Mo.D. 1942, Pub.C. I 171, Pub.C. I1249, Pub.D. I1399, Th.C.4607, Th.D.4955, Th.D.5O I 3,Tu.C.2649, We.D.3654, We.D.3664, We.D.3667, We.D.381I5, We.D.490, We.D.494, We.D.495 cross-reactivity Mo.A.1SI, Mo.A.273,Th.B.4204, Tu.A.2099, We.B.3378, We.B.3379 cryptococcosis Mo.B. 1227, Mo.B. 1228, Mo.B. 1231, Th.A.4062, Th. B.4203, Th. B.4204, Tu.B. I 86,Tu.B.2 I 93,Tu.B.2 195, We.A.3086 cryptococcus M o.B. 1227, M o.B. 1231,Th.A.405 2, Th. B.4206, Tu. B. I186, Tu. B.2 I193, Tu.B8.2 19S, Tu.B.2357, We.A.3086 cryptosporidiosis Mo.B. 1333, MoC. I1674, Pub.A. 1028, Pub.B. 1056, Pub.B. I 068,Th.A.406 I, Th. B.42 I I, Th. B.42 I15, Th.B8.42 16, Th.B.4268,Tu.B.2322, We.B.3245 CSF, SEE cerebrospinal fluid Mo.B. I123 I,Tu.B.2 193 cultural practices MoC. 1477, Mo.C.223, Mo.D. 1708, Mo.D. 1884, Mo.D.480, Mo.D.48 I, Mo.D.482, Mo.D.483, Mo.D.484, cultural studies Mo.A. I I14, Mo.D. I690, Mo.D. I863. Mo.D.1904, Mo. D.1925, Pub.A.10 13, Pub.B. 103S. Pub.B. I1074, Pub.C. I1273, Pub.D. I1392, Pub.D. 141 7, Th.A.1032, Th.C.44 I 3,Th.C.4826,Th.D.4996, Th.D.S 101 Tu.B. I 70,Tu.B.54 I,Tu.C.2648, Tu. C. 334, Tu. D.27 16, Tu. D. 2765, Tu.D.2786,Tu.D.284 I, Tu.D.2854, Tu. D.2864, Tu. D2865, We. A. 302 7, We.A.3028, We.D.3 /89, We.D.472 culture, B cells Th.A.273, We.C.3390 culture, bioassay Mo.A. 1003, Mo.A. I1089, Th.A. I153, Th.A.4064,Tu.C.2588, We.B.424 culture, CD4 enriched Mo.A.I 1 17, Mo.A.S0l, Tu.A.271, We.A.405 culture, endothelium Mo.B. 1I0,290,Tu.A. I143 culture, monocytes, macrophages Mo.A. 1004, Mo.A. I1056, We.A.307 1, We.A.3 I107, We.B.32 37 culture, neural cell We.B.3290 culture, placenta We.A.3 I107, Mo.A. I 11I4, Th.8.4345, Tu.A.2069, Tu. D.2 84 I culture, promonocytes Tu.A.2030 culture,T cells Mo.A. 1037, Mo.A. 1080, Mo.A. 1096, Mo.A.I1101, Pub.A.I0I5, Th.A.I100, Th.A. 1ISTh.A. I140,Tu.A.2 71I,Tu.A.390, We.A. I 54, We.A.264, We.A.3009, We.A.3032, We.A.306 I culture, thymic cell We.A.272 cyclosporine Th.B.433 I cysteine Mo.A. 1089. Mo.A. 1090 cytokines Mo.A. 1004, Mo.A. 1025, Mo.A. 1064, Mo.A. I1107, Mo.A. 141, Mo.A. 142, Mo.A. 145, Mo.A.394, Mo.A.402, Mo.A.S03, Mo.A.52 1, Mo.B. I1258, Mo.B. 1285, Mo.8.1319, Mo.B.43 I, Pub.A. 1026, PubA. 1027. Th.A. 103, Th.A. 160, Th.A.161.YhhA. 62, Th.A. 164, Th.A. I165, Th.A.4072,Th. B. I 76, Th. B.4 I108. Th.B.4 I 77,Th.B.4 I 84.Th.B.4300, Th. B.43 I10, Tu.A.2002,Tu.A.2008, Tu.A.20 10, Tu.A.20 12, Tu.A.201 3, Tu.A.2030, Tu.A.2044, Tu.A.2 100. Tu.A.38 I,Tu.A.383,Tu.A.390,Tu.A.39 I, Tu.A.392, Tu.A.393, Tu.A.S0, Wo.A. 162, We.A.28 I, We.A.3032, We.A.3049, We.A.3065, We.A.3067, We.A.307 I, We.A.3073, We.A.3083, We.A.3084, We.A.3085, We.A. 3086, We.A. 3089, We.A.3090, We.A.3092, We.A. 3093, We.A.3095, We.A.3096, We.A.3097, We.A.3098, We.A.3 I100, We.A.3 101, We.A. 3102, We.A. 3104, We.A. 3107, We.A.3 I108, We.A.384, We.A.503, cytomegalovirus, other Th.A.4055, Th.B. 300,. 1.8.21I87, Tu.C.2576 N-O 0 V C 0 0 v a) 0 0 cO 481

/ 516
Pages

Actions

file_download Download Options Download this page PDF - Pages 441-490 Image - Page 481 Plain Text - Page 481

About this Item

Title
Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]
Author
International AIDS Society
Canvas
Page 481 - Comprehensive Index
Publication
1996
Subject terms
abstracts (summaries)
Item type:
abstracts (summaries)

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0110.046
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0110.046/491

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0110.046

Cite this Item

Full citation
"Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0110.046. University of Michigan Library Digital Collections. Accessed May 12, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel